CA2564591A1 - Structure de silicium - Google Patents
Structure de silicium Download PDFInfo
- Publication number
- CA2564591A1 CA2564591A1 CA002564591A CA2564591A CA2564591A1 CA 2564591 A1 CA2564591 A1 CA 2564591A1 CA 002564591 A CA002564591 A CA 002564591A CA 2564591 A CA2564591 A CA 2564591A CA 2564591 A1 CA2564591 A1 CA 2564591A1
- Authority
- CA
- Canada
- Prior art keywords
- silicon
- unitary body
- particulate product
- particles
- porous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 title claims abstract description 376
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 335
- 239000010703 silicon Substances 0.000 claims abstract description 335
- 238000000034 method Methods 0.000 claims abstract description 91
- 229910021426 porous silicon Inorganic materials 0.000 claims abstract description 86
- 239000011856 silicon-based particle Substances 0.000 claims description 143
- 239000000126 substance Substances 0.000 claims description 121
- 230000009286 beneficial effect Effects 0.000 claims description 106
- 230000008569 process Effects 0.000 claims description 59
- 239000000243 solution Substances 0.000 claims description 40
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 38
- 239000002245 particle Substances 0.000 claims description 32
- 238000003825 pressing Methods 0.000 claims description 20
- 239000002131 composite material Substances 0.000 claims description 11
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 8
- 238000005530 etching Methods 0.000 claims description 7
- 229910000077 silane Inorganic materials 0.000 claims description 7
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 238000007743 anodising Methods 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 229910052990 silicon hydride Inorganic materials 0.000 claims 1
- 238000007596 consolidation process Methods 0.000 abstract description 17
- 150000002433 hydrophilic molecules Chemical class 0.000 abstract description 16
- 238000004519 manufacturing process Methods 0.000 abstract description 13
- 238000011068 loading method Methods 0.000 abstract description 8
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000047 product Substances 0.000 description 105
- 239000011148 porous material Substances 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 238000002048 anodisation reaction Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 239000012528 membrane Substances 0.000 description 12
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 239000007789 gas Substances 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 11
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 11
- 239000008188 pellet Substances 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 125000004429 atom Chemical group 0.000 description 9
- 239000011575 calcium Substances 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 229910052796 boron Inorganic materials 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 229910021419 crystalline silicon Inorganic materials 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003792 electrolyte Substances 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 8
- 229910021417 amorphous silicon Inorganic materials 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 229910052698 phosphorus Inorganic materials 0.000 description 7
- 238000001878 scanning electron micrograph Methods 0.000 description 7
- 229910052718 tin Inorganic materials 0.000 description 7
- 229910052727 yttrium Inorganic materials 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229910052785 arsenic Inorganic materials 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 238000012377 drug delivery Methods 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000000565 sealant Substances 0.000 description 6
- 239000011863 silicon-based powder Substances 0.000 description 6
- 229910008045 Si-Si Inorganic materials 0.000 description 5
- 229910006411 Si—Si Inorganic materials 0.000 description 5
- 229910052787 antimony Inorganic materials 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229910052738 indium Inorganic materials 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 229910052741 iridium Inorganic materials 0.000 description 5
- 229910052746 lanthanum Inorganic materials 0.000 description 5
- 229910052745 lead Inorganic materials 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 239000000825 pharmaceutical preparation Substances 0.000 description 5
- 229940127557 pharmaceutical product Drugs 0.000 description 5
- 229910052814 silicon oxide Inorganic materials 0.000 description 5
- 229910052712 strontium Inorganic materials 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 235000012431 wafers Nutrition 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 238000005229 chemical vapour deposition Methods 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 102000008070 Interferon-gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005056 compaction Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007731 hot pressing Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229960003130 interferon gamma Drugs 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 102100024028 Progonadoliberin-1 Human genes 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 229910000676 Si alloy Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 206010057644 Testis cancer Diseases 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 229940122803 Vinca alkaloid Drugs 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 229910052810 boron oxide Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960004630 chlorambucil Drugs 0.000 description 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XWHPIFXRKKHEKR-UHFFFAOYSA-N iron silicon Chemical compound [Si].[Fe] XWHPIFXRKKHEKR-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000005543 nano-size silicon particle Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000009747 press moulding Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- SBEQWOXEGHQIMW-UHFFFAOYSA-N silicon Chemical compound [Si].[Si] SBEQWOXEGHQIMW-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L31/00—Semiconductor devices sensitive to infrared radiation, light, electromagnetic radiation of shorter wavelength or corpuscular radiation and specially adapted either for the conversion of the energy of such radiation into electrical energy or for the control of electrical energy by such radiation; Processes or apparatus specially adapted for the manufacture or treatment thereof or of parts thereof; Details thereof
- H01L31/18—Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L31/00—Semiconductor devices sensitive to infrared radiation, light, electromagnetic radiation of shorter wavelength or corpuscular radiation and specially adapted either for the conversion of the energy of such radiation into electrical energy or for the control of electrical energy by such radiation; Processes or apparatus specially adapted for the manufacture or treatment thereof or of parts thereof; Details thereof
- H01L31/18—Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof
- H01L31/1804—Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof comprising only elements of Group IV of the Periodic Table
- H01L31/182—Special manufacturing methods for polycrystalline Si, e.g. Si ribbon, poly Si ingots, thin films of polycrystalline Si
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P70/00—Climate change mitigation technologies in the production process for final industrial or consumer products
- Y02P70/50—Manufacturing or production processes characterised by the final manufactured product
Landscapes
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Electromagnetism (AREA)
- General Physics & Mathematics (AREA)
- Computer Hardware Design (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Silicon Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0411358A GB2414231A (en) | 2004-05-21 | 2004-05-21 | Porous silicon |
| GB0411358.5 | 2004-05-21 | ||
| PCT/GB2005/001910 WO2005113467A1 (fr) | 2004-05-21 | 2005-05-18 | Structure de silicium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2564591A1 true CA2564591A1 (fr) | 2005-12-01 |
Family
ID=32607728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002564591A Abandoned CA2564591A1 (fr) | 2004-05-21 | 2005-05-18 | Structure de silicium |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1747180A1 (fr) |
| JP (1) | JP2007537965A (fr) |
| CA (1) | CA2564591A1 (fr) |
| GB (1) | GB2414231A (fr) |
| WO (1) | WO2005113467A1 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0601319D0 (en) | 2006-01-23 | 2006-03-01 | Imp Innovations Ltd | A method of fabricating pillars composed of silicon-based material |
| FR2915742B1 (fr) * | 2007-05-04 | 2014-02-07 | Centre Nat Rech Scient | Procede pour la fourniture du dihydrogene a partir de silicium hydrogene |
| GB0709165D0 (en) | 2007-05-11 | 2007-06-20 | Nexeon Ltd | A silicon anode for a rechargeable battery |
| GB0713898D0 (en) | 2007-07-17 | 2007-08-29 | Nexeon Ltd | A method of fabricating structured particles composed of silcon or a silicon-based material and their use in lithium rechargeable batteries |
| GB0713895D0 (en) | 2007-07-17 | 2007-08-29 | Nexeon Ltd | Production |
| GB0713896D0 (en) | 2007-07-17 | 2007-08-29 | Nexeon Ltd | Method |
| GB2464158B (en) | 2008-10-10 | 2011-04-20 | Nexeon Ltd | A method of fabricating structured particles composed of silicon or a silicon-based material and their use in lithium rechargeable batteries |
| GB2464157B (en) | 2008-10-10 | 2010-09-01 | Nexeon Ltd | A method of fabricating structured particles composed of silicon or a silicon-based material |
| GB2470056B (en) | 2009-05-07 | 2013-09-11 | Nexeon Ltd | A method of making silicon anode material for rechargeable cells |
| GB2470190B (en) | 2009-05-11 | 2011-07-13 | Nexeon Ltd | A binder for lithium ion rechargeable battery cells |
| US9853292B2 (en) | 2009-05-11 | 2017-12-26 | Nexeon Limited | Electrode composition for a secondary battery cell |
| GB201005979D0 (en) | 2010-04-09 | 2010-05-26 | Nexeon Ltd | A method of fabricating structured particles composed of silicon or a silicon-based material and their use in lithium rechargeable batteries |
| GB201009519D0 (en) | 2010-06-07 | 2010-07-21 | Nexeon Ltd | An additive for lithium ion rechargeable battery cells |
| GB201014707D0 (en) | 2010-09-03 | 2010-10-20 | Nexeon Ltd | Electroactive material |
| GB201014706D0 (en) * | 2010-09-03 | 2010-10-20 | Nexeon Ltd | Porous electroactive material |
| WO2012109459A1 (fr) * | 2011-02-09 | 2012-08-16 | Hariharan Alleppey V | Récupération de valeur de silicium dans des rebuts de coupe de silicium |
| GB2529409A (en) * | 2014-08-18 | 2016-02-24 | Nexeon Ltd | Electroactive materials for metal-ion batteries |
| US10882751B2 (en) | 2015-09-29 | 2021-01-05 | C-Crete Technologies, Llc | Calcium-silicate-based porous particles, composition, method of making and use thereof |
| FR3075826B1 (fr) * | 2017-12-22 | 2019-12-20 | Nanomakers | Procede de fabrication incorporant des particules a base de silicium |
| JP2021042112A (ja) * | 2019-09-13 | 2021-03-18 | 株式会社トクヤマ | 精製シリコン微粒子の製造方法 |
| JP7464254B2 (ja) * | 2020-02-26 | 2024-04-09 | 国立大学法人広島大学 | 金属材料及び水素の製造方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4040848A (en) * | 1976-01-06 | 1977-08-09 | General Electric Company | Polycrystalline silicon articles containing boron by sintering |
| DE3236276A1 (de) * | 1982-09-30 | 1984-04-05 | Heliotronic Forschungs- und Entwicklungsgesellschaft für Solarzellen-Grundstoffe mbH, 8263 Burghausen | Neuer werkstoff aus silicium und verfahren zu seiner herstellung |
| DE3518829A1 (de) * | 1985-05-24 | 1986-11-27 | Heliotronic Forschungs- und Entwicklungsgesellschaft für Solarzellen-Grundstoffe mbH, 8263 Burghausen | Verfahren zur herstellung von formkoerpern aus siliciumgranulat fuer die erzeugung von siliciumschmelzen |
| DE3613778A1 (de) * | 1986-04-23 | 1987-10-29 | Heliotronic Gmbh | Verfahren zur herstellung von formkoerpern aus granulat auf der basis von silicium, germanium oder mischkristallen dieser elemente |
| JPH01100010A (ja) * | 1987-10-14 | 1989-04-18 | Canon Inc | 非晶質水素化シリコン微粒子膜及びその製造方法 |
| JP3259247B2 (ja) * | 1993-03-11 | 2002-02-25 | 理化学研究所 | ポーラス・シリコンおよびその製造方法 |
| JPH08109012A (ja) * | 1994-10-11 | 1996-04-30 | Tonen Corp | 多結晶シリコン板の製造方法 |
| GB9611437D0 (en) * | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
| JPH11314911A (ja) * | 1998-05-07 | 1999-11-16 | Sumitomo Sitix Amagasaki:Kk | 多結晶シリコンインゴットの製造方法 |
| GB2363115A (en) * | 2000-06-10 | 2001-12-12 | Secr Defence | Porous or polycrystalline silicon orthopaedic implants |
| GB0212667D0 (en) * | 2002-05-31 | 2002-07-10 | Psimedica Ltd | Orthopaedic scaffolds for tissue engineering |
| JP4608654B2 (ja) * | 2002-06-18 | 2011-01-12 | 財団法人新産業創造研究機構 | 一重項酸素発生光増感剤及びそれを用いた一重項酸素発生方法 |
| FR2858313B1 (fr) * | 2003-07-28 | 2005-12-16 | Centre Nat Rech Scient | Reservoir d'hydrogene a base de nano-structures de silicium |
-
2004
- 2004-05-21 GB GB0411358A patent/GB2414231A/en not_active Withdrawn
-
2005
- 2005-05-18 WO PCT/GB2005/001910 patent/WO2005113467A1/fr not_active Application Discontinuation
- 2005-05-18 CA CA002564591A patent/CA2564591A1/fr not_active Abandoned
- 2005-05-18 EP EP05745011A patent/EP1747180A1/fr not_active Withdrawn
- 2005-05-18 JP JP2007517409A patent/JP2007537965A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005113467A1 (fr) | 2005-12-01 |
| EP1747180A1 (fr) | 2007-01-31 |
| GB0411358D0 (en) | 2004-06-23 |
| JP2007537965A (ja) | 2007-12-27 |
| GB2414231A (en) | 2005-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2564591A1 (fr) | Structure de silicium | |
| US8500843B2 (en) | Controlled porosity article | |
| US7674426B2 (en) | Porous metal articles having a predetermined pore character | |
| US10978712B2 (en) | Process for the manufacture of gas diffusion electrodes | |
| EP0392738A1 (fr) | Structures métalliques, micro- et nano poreuses | |
| Dewidar et al. | Properties of solid core and porous surface Ti–6Al–4V implants manufactured by powder metallurgy | |
| JP4219325B2 (ja) | 多孔性チタン材料物品の製造方法 | |
| JP2014528740A (ja) | インプラント | |
| TW201219591A (en) | Tungsten target and tungsten target manufacturing method | |
| KR20110065391A (ko) | 마그네슘 합금을 이용한 약물 전달체 | |
| KR101331027B1 (ko) | 균일한 분포의 나노 기공을 가지는 메탈폼 제조방법 및 이에 의해 제조된 메탈폼 | |
| CA2584896A1 (fr) | Structure de silicium | |
| JP3837502B2 (ja) | 生体用多孔質複合体、その製造方法及びその用途 | |
| EP3595832B1 (fr) | Matériau métallique fritté à porosité orientée comprenant au moins une partie ferromagnétique et procédé de fabrication | |
| EP2939761B1 (fr) | Procédé de fabrication d'un produit granulé à base de niobium, procédé de fabrication d'un corps fritté, procédé de fabrication d'un corps de conversion chimique pour électrode positive de condensateur et procédé de fabrication d'un condensateur | |
| CN110157936A (zh) | 一种生物医用有序多孔的铸态锌基材料的制备方法 | |
| US12106968B2 (en) | Injection metal assisted catalytic etching | |
| JP3551355B2 (ja) | Ｒｕターゲットおよびその製造方法 | |
| JP2005226140A (ja) | チタン−ハイドロキシアパタイト複合体 | |
| JP2673515B2 (ja) | ポーラスコートインプラントの製造方法 | |
| KR101689387B1 (ko) | 표면에 메탈폼층을 구비한 금속 기재 제조방법 및 이에 의해 제조된 금속 기재 | |
| EP3351519A1 (fr) | Nouveau corps de phosphate de calcium fritté et son procédé de fabrication | |
| WO2007112554A1 (fr) | Procédé servant à recouvrir partiellement des matières poreuses à alvéoles ouverts | |
| JPH05271702A (ja) | Ｃｕ−Ｗ焼結体の製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |